JPM vs VOR Stock Comparison
VOR currently leads JPM in this stock comparison, with AIQ scores of 66 vs 65. The clearest difference is balanced, while JPM has the stronger risk resilience profile.
What is the main difference between JPM and VOR?
VOR leads the current stock comparison as Vor Biopharma Inc., with the clearest separation coming from balanced and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
JPMorgan Chase & Co. vs Vor Biopharma Inc.
VOR leads
VOR leads by 1 AIQ points, but the lead has narrowed from 4 points over 30 sessions.
Fragile: 2 of 5 evidence groups support VOR, its lead is narrowing, and its current signal state is conflicted.
JPMorgan Chase & Co.
Vor Biopharma Inc.
The Algovestiq AIQ Score currently favors VOR over JPM, 66 versus 65 as of Nov 15, 2026. VOR also shows the weaker technical structure relative to its 50-day moving average. 2 of 5 covered evidence groups favor VOR today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. VOR lead: Weakening — the AIQ differential moved from 4 to 1 points over 30 sessions.
Compare JPMorgan Chase & Co. and Vor Biopharma Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare JPM and VOR against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience87 vs 46JPM +41
- Quality86 vs 69JPM +17
- Momentum70 vs 72Even
2 of 5 evidence groups favor VOR. Neither name separates cleanly on the covered dimensions.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +1, not enough on its own to move the overall score.
New signals
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
Largest factor move: Momentum +2
New signals
- TSI Bearish Crossover — bearish, momentum, short horizon
VOR's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — JPM and VOR both carry a full feed there.
The central trade-off
VOR (Vor Biopharma Inc.): the stronger current systematic profile.
JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, quality.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
VORVOR on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
VORVOR on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
EvenThe two are level on Momentum.
Lower downside
JPMJPM on Risk Resilience, by 41 points.
Analyst upside
VORVOR on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | JPM | VOR | Note |
|---|---|---|---|
| Implied upside to target | +7.8% | +106% | VOR has more room |
| Target dispersion | +30.3% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 26 | 10 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 5 covered evidence groups favor VOR. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 65 vs 66 |
| Fundamentals | VOR | EPS growth -27.6% vs -25%; TTM ROE 4.1% vs 63.2% |
| Valuation | Not covered | Not covered |
| Technicals | Even | Price vs 50-day 1.7% vs -2.9%; vs 200-day 6.6% vs 10.8% |
| Risk Resilience | JPM | Risk Resilience 87 vs 46 |
| Analyst expectations | VOR | Target upside 7.8% vs 106% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of JPM and VOR and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on VOR.
How the comparison changed
120 daily snapshots · May 27 – Nov 13VOR lead: Weakening — the AIQ differential moved from 4 to 1 points over 30 sessions.
- Today
- VOR +1
- 65 vs 66
- 7 sessions ago
- JPM +1
- 64 vs 63
- 30 sessions ago
- VOR +4
- 63 vs 67
- 90 sessions ago
- VOR +5
- 64 vs 69
The lead changed hands 4 times in this window, most recently on Nov 10 when VOR moved ahead of JPM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
6 bullish / 1 bearish / 1 neutral, conflicted
Only JPM
- Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
1 bullish / 2 bearish / 1 neutral, conflicted
Only VOR
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (6.32%)
- Beta Spike Warning — bearish, risk_regime, long horizon
- TSI Bearish Crossover — bearish, momentum, short horizon
Both carry 1 more signal that do not separate them: Golden Cross Active.
VOR leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +0.52%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 2VOR's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 3The narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 1-point move would eliminate VOR's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
VOR leads on balance| Metric | JPM | VOR |
|---|---|---|
| Revenue growth (YoY) | -7.6% | 0% |
| EPS growth (YoY) | -27.6% | -25% |
| Gross margin | 63.2% | 0% |
| Operating margin | 28.2% | 0% |
| Return on equity (TTM) | 4.1% | 63.2% |
| Debt to equity | 3.32 | -0.02 |
Performance
VOR leads 4 of 6 windows| Metric | JPM | VOR |
|---|---|---|
| 1 week (5 sessions) | 3.5% | -2.3% |
| 1 month (20 sessions) | 1.9% | 7.7% |
| 3 months (63 sessions) | -4.1% | -15.6% |
| 6 months (126 sessions) | 16.2% | 32.7% |
| Year to date | 7.4% | 48.5% |
| 1 year (252 sessions) | 8% | 93% |
Technicals
Split| Metric | JPM | VOR |
|---|---|---|
| RSI (14) | 56.1 | 48.8 |
| ADX (14) | 18 | 8.9 |
| Price vs 50-day | 1.7% | -2.9% |
| Price vs 200-day | 6.6% | 10.8% |
| Volatility (1M, annualized) | 27.4% | 62.1% |
Risk
JPM is the more resilient| Metric | JPM | VOR |
|---|---|---|
| Beta | 0.78 | 1.7 |
| Sharpe ratio | 0.44 | 1.15 |
| Sortino ratio | 0.61 | 1.99 |
| Max drawdown | -15.5% | -33.4% |
| Current drawdown | -5.2% | -22.6% |
| Annualized volatility | 22.7% | 93.5% |
| Value at risk (95%) | -2.4% | -8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, JPM or VOR?
On the Algovestiq AIQ Score, VOR is the stronger of the two as of Nov 15, 2026, scoring 66 against JPM's 65. The edge comes from its factor profile. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is JPM or VOR the better buy right now?
VOR carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor VOR over JPM?
The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Risk Resilience by 41 points; JPM leads Quality by 17 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, JPM or VOR?
Analyst price targets imply +7.8% upside for JPM and +106% for VOR, so the Street currently favors VOR. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, JPM or VOR?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, JPM or VOR?
VOR on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, JPM or VOR?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, JPM or VOR?
JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 41 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is JPM more profitable than VOR?
VOR leads on the comparable margin measures — gross margin 63.2% vs 0%; operating margin 28.2% vs 0%; ttm roe 4.1% vs 63.2%.
Is VOR's lead over JPM getting stronger or weaker?
VOR lead: Weakening — the AIQ differential moved from 4 to 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 4 times in that window, most recently on 2026-11-10, when VOR moved ahead of JPM.
What would change the JPM vs VOR verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; VOR's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 1-point move would eliminate VOR's advantage entirely.
What do the current signals say about JPM and VOR?
JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. VOR: 1 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on JPM is Golden Cross Active (bullish, long horizon). On VOR it is Golden Cross Active (bullish, long horizon).
Compare JPM and VOR with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.